U.S. Food and Drug Administration Business Systems Analyst Salaries in Boulder
The average U.S. Food and Drug Administration Business Systems Analyst in Boulder earns an estimated $83,105 annually, which includes an estimated base salary of $77,064 with a $6,041 bonus. U.S. Food and Drug Administration's Business Systems Analyst compensation is $365 less than the US average for a Business Systems Analyst. Business Systems Analyst salaries at U.S. Food and Drug Administration in Boulder can range from $52,000 - $121,000.
In Boulder, The Operations Department at U.S. Food and Drug Administration earns $11,395 more on average than the Admin Department.
Last updated 3 years ago.
- $77,064
- avg. base
- $6,041
- avg. bonus
Business Systems Analyst Salaries at U.S. Food and Drug Administration
In Boulder, Business Systems Analysts earn $2,921 more than Business Analysts, and $12,274 less than Operations Managers.
Compensation at U.S. Food and Drug Administration by Department
In Boulder, The Operations Department averages $11,395 more than the Admin Department, and $5,324 less than the Finance Department
Business Systems Analyst Compensation by Gender (All Companies)
The average female Business Systems Analyst at companies similar size to U.S. Food and Drug Administration reported making $89,933, while the average male Business Systems Analyst at similar sized companies reported making $93,781.
Business Systems Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Systems Analyst at companies similar size to U.S. Food and Drug Administration reported making $115,000, while the average African American/Black Business Systems Analyst at similar sized companies reported making $75,705.
How Business Systems Analysts at U.S. Food and Drug Administration Rate Their Compensation
The majority of Business Systems Analysts at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Business Systems Analysts at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
